EGFR and cancer: Furthermore, 175 KEGG pathways were enriched, which mainly involved neuroactive ligand–receptor interactions, proteoglycans in cancer, pathways in cancer, the EGFR tyrosine kinase pathway, and the PI3K-Akt signaling pathway, as shown in Figure S4E.